Tulsa Retina Consultants
Tulsa, Oklahoma 74133
2 studies enrolling now · 11 studies all time
What they study most
Age-Related Macular Degeneration, Age-related Macular Degeneration (AMD), Choroidal Neovascularization, Diabetes Mellitus, Diabetic Macular Edema, Diabetic Macular Edema (DME), Diabetic Retinopathy, Geographic Atrophy, Geographic Atrophy (GA), Macular Degeneration, Macular Telangiectasia Type 2, Macular Telangiectasia Type 2 (MacTel)
Studies at this site
- A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) — Recruiting now
- A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy — Recruiting now
- A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS) — Recruiting now
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema — Completed
- A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA) — Running, not enrolling
- A Phase 3b, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Weeks in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME) — Running, not enrolling
- Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Retinal Vein Occlusion — Completed
- A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol B — Completed
- A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol A — Completed
- A Study to Evaluate THR-687 Treatment for Diabetic Macular Oedema. — Stopped early
- Phase 4 IOP Signals Associated With ILUVIEN® — Completed